跳至主要内容
临床试验/IRCT20090117001556N116
IRCT20090117001556N116招募中3 期

Pentoxifylline as adjuvant therapy in the treatment of major depression: a randomised and double blind study

Tehran University of Medical Sciences0 个研究点目标入组 50 人开始时间: 待定最近更新:
适应症

试验速览

阶段
3 期
状态
招募中
入组人数
50

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional

入排标准

年龄范围
18 years 至 50 years(—)
性别
All

入选标准

  • Presence of Major Depressive Disorder based on DSM-5 criteria
  • Baseline Hamilton Depression Rating Scale (HAM-D) (17-item) score of at least 19

排除标准

  • Presence of psychosis
  • Any other mental disorder
  • Hypothyroidism
  • Cardiovascular disease
  • Pregnancy or nursing women
  • Renal failure
  • Allergy to Theophylline, Aminophylline, and pentoxyfylline
  • Hepatic failure
  • Peptic ulcer
  • Receiving antiplatelets agents or anticoagulants
  • Receiving NSAIDs

研究者

相似试验

Pentoxifylline as adjuvant therapy in the treatment... | 临床试验